İltemir Duvan Z Candan, Namlı Kalem Müberra, Onaran Yuksel, Aktepe Keskin Esra, Ayrım Aylin, Pekel Aslıhan, Kafalı Hasan, Turhan Nilgün
Department of Obstetrics and Gynaecology, School of Medicine, Turgut Ozal University, Ankara, Turkey.
Department of IVF-Embriology, School of Medicine, Turgut Ozal University, Ankara, Turkey.
Int J Fertil Steril. 2017 Apr-Jun;11(1):1-6. doi: 10.22074/ijfs.2016.5144. Epub 2016 Nov 11.
Coasting can reduce the ovarian hyperstimulation syndrome (OHSS) risk in ovulation induction cycles before intracytoplasmic sperm injection (ICSI). This study aimed to investigate the effect of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist protocols to controlled ovarian hyperstimulation (COH) cycles with coasting on the parameters of ICSI cycles and the outcome.
In a retrospective cohort study, 117 ICSI cycles were per- formed and coasting was applied due to hyperresponse, between 2006 and 2011. The ICSI outcomes after coasting were then compared between the GnRH agonist group (n=91) and the GnRH antagonist group (n=26).
The duration of induction and the total consumption of gonadotropins were found to be similar. Estradiol (E) levels on human chorionic gonadotropin (hCG) day were found higher in the agonist group. Coasting days were similar when the two groups were compared. The number of mature oocytes and the fertilization rates were similar in both groups; however, the number of grade 1 (G1) embryos and the number of transferred embryos were higher in the agonist group. Implantation rates were significantly higher in the antagonist group compared to the agonist group. Pregnancy rates/embryo transfer rates were higher in the antagonist group; however, this difference was not statistically significant (32.8% for agonist group vs. 39.1% for antagonist group, P>0.05).
The present study showed that applying GnRH-agonist and GnRH-antago- nist protocols to coasted cycles did not result in any differences in cycle parameters and clinical pregnancy rates.
在卵胞浆内单精子注射(ICSI)前的促排卵周期中,“降调节”可降低卵巢过度刺激综合征(OHSS)的风险。本研究旨在探讨促性腺激素释放激素(GnRH)激动剂方案和GnRH拮抗剂方案应用于“降调节”的控制性卵巢刺激(COH)周期对ICSI周期参数及结局的影响。
在一项回顾性队列研究中,2006年至2011年间共进行了117个ICSI周期,因卵巢反应过度而采用“降调节”。然后比较GnRH激动剂组(n = 91)和GnRH拮抗剂组(n = 26)“降调节”后的ICSI结局。
诱导时间和促性腺激素的总用量相似。人绒毛膜促性腺激素(hCG)日的雌二醇(E)水平在激动剂组中较高。两组比较时,“降调节”天数相似。两组成熟卵母细胞数量和受精率相似;然而,1级(G1)胚胎数量和移植胚胎数量在激动剂组中较高。拮抗剂组的着床率显著高于激动剂组。拮抗剂组的妊娠率/胚胎移植率较高;然而,这种差异无统计学意义(激动剂组为32.8%,拮抗剂组为39.1%,P>0.05)。
本研究表明,在“降调节”周期中应用GnRH激动剂方案和GnRH拮抗剂方案在周期参数和临床妊娠率方面未产生任何差异。